Rahul Ravindran

1.     How did you become interested in translational gastroenterology?

My interest in translational gastroenterology stemmed from a desire to bridge the gap between clinical practice and the scientific underpinning of the diseases that patients have. I was particularly drawn to the field of gastroenterology as it covers a wide range of organs and diverse aetiologies of disease. The potential to translate scientific discoveries into practical treatments that can improve patient outcomes motivated me to pursue a career in this field.

2.     What are you currently working on and what importance does your work hold for current patients with gastrointestinal issues?

Currently, I am working on improving our understanding of the pathophysiology of inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. My research focuses on identifying the pathways of exit from the intestinal tissue, which is via specialised vessels called ‘lymphatic vessels’. By developing our knowledge in this area, it may be possible to stimulate exit of inflammatory contents from the intestine as an alternative way of treating patients. I hope these insights will ultimately improve the quality of life for those suffering from these chronic conditions.

3.     What do you enjoy most about scientific research?

I really enjoy the discovery and continuous learning in scientific research. The process of formulating hypotheses, conducting experiments, and analysing data is intellectually stimulating and rewarding. Additionally, the collaborative nature of research allows me to work with people from diverse fields, fostering innovation and creativity.

4.     What’s the best part of being an Oxford University TGLU member?

The best part of being a TGLU member is the opportunity to work in a team at the interface of science and medicine. The TGLU brings together people from across the hospital and university to work on important questions related to human diseases. The range of expertise in Oxford enables me to pursue a career where I can truly link my clinical work with a cellular and molecular understanding of the diseases that we treat.